Dihidro-&bgr;-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3125-3139

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer

By Xu H-W   Xu L   Hao J-H   Qin C-Y   Liu H  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 34-42

Field House Publishing

Access to resources Recommend Favorite

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

By Baranck M.   Bohacova V.   Kvackajova J.   Hudecova S.   Krizanova O.   Breier A.  

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of Multidrug Resistance by the P-Glycoprotein Modulator, LY335979, from the Bench to the Clinic

By  

Current Medicinal Chemistry, Vol. 8, Iss. 1, 2001-01 ,pp. : 39-50

Bentham Science Publishers

Access to resources Recommend Favorite